TrademarkDir
MAESTRO RX
LIVE

Serial Number

86735380

Owner

Patients' and Consumers' Pharmaceutical Company Inc.

Attorney

Joel E. Tragesser

First Use Date

Oct 1, 2015

Filing Date

Aug 24, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MAESTRO RX Trademark

Serial Number: 86735380 • Registration: 5375721

MAESTRO RX is a trademark filed by Patients' and Consumers' Pharmaceutical Company Inc. on August 24, 2015. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Patients' and Consumers' Pharmaceutical Company Inc. (5 trademarks)

7575 Paragon Road
Dayton, OH 45459

Entity Type: 03

Patients' and Consumers' PharmaceuticalCompany Inc.

7575 Paragon Road
Dayton, OH 45459

Entity Type: 03

Trademark Details

Filing Date

August 24, 2015

Registration Date

January 9, 2018

First Use Anywhere

October 1, 2015

First Use in Commerce

January 15, 2016

Published for Opposition

March 14, 2017

Goods & Services

Providing temporary use of non-downloadable cloud-based software featuring a proprietary database of formulations and stability information for use by pharmacies in the field of custom compounding of pharmaceuticals

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 9, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 9, 2024 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 9, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 2, 2024 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 15, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 15, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 15, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 15, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 15, 2023 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 9, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 7, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 6, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 16, 2017 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 13, 2017 AITU
USE AMENDMENT FILED
Oct 30, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 30, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 9, 2017 NOAM
POST PUBLICATION AMENDMENT - ENTERED
Apr 14, 2017 CHPB
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2017 COAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 20, 2017 EWAF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 7, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2017 TROA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 3, 2017 EWAF
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 8, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jul 8, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jul 8, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2015 GNRN
NON-FINAL ACTION E-MAILED
Dec 15, 2015 GNRT
NON-FINAL ACTION WRITTEN
Dec 15, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 7, 2015 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 28, 2015 AMPX
ASSIGNED TO LIE
Oct 23, 2015 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 2, 2015 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 28, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2015 NWOS
NEW APPLICATION ENTERED
Aug 27, 2015 NWAP

Related Trademarks

More from this Owner

P&C PHARMA

P&C PHARMA

P&C PHARMA

P&C PHARMA

P&C PHARMA

P&C PHARMA

P&C PHARMA logo

P&C PHARMA

P&C PHARMA logo

P&C PHARMA

P&C PHARMA logo

P&C PHARMA